CTXR - Company ID 0001506251
Citius Pharmaceuticals, Inc. trades as CTXR. This page tracks Citius Pharmaceuticals, Inc. through 625 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Next research step
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Net profit margin compressed from -20769.9% to -37378.5% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Securities registration | S-3 | 2026-05-22 |
| Major company event | 8-K | 2026-05-15 |
| Quarterly report | 10-Q | 2026-05-15 |
| Major company event | 8-K | 2026-05-08 |
| Major company event | 8-K | 2026-04-29 |
| Major company event | 8-K | 2026-04-24 |
| Prospectus supplement | 424B5 | 2026-04-24 |
| Major company event | 8-K | 2026-04-06 |
The largest companies sharing Citius Pharmaceuticals, Inc.'s SEC industry classification (pharmaceutical preparations).